Compass Pathways Plc ADR (CMPS)

NASD · Healthcare · Medical Care Facilities · United Kingdom

Compass Pathways Plc ADR is a small cap company (market value between $300 million and $2 billion) in the Medical Care Facilities industry.

Compass Pathways Plc is a biotechnology company developing COMP360, an investigational psilocybin treatment for mental health conditions. The company is conducting clinical trials for treatment-resistant depression, the primary indication, and for post-traumatic stress disorder. Compass Pathways is advancing clinical development to support potential regulatory approval and commercialization of its proprietary psilocybin formulation.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Compass Pathways Plc ADR stock.

Our verdict on CMPS

Not valued: We cannot value this company yet.

ETFs with the most weight in CMPS

• ARK Genomic Revolution ETF (ARKG): 3.3% of the fund
• iShares Biotechnology ETF (IBB): 0.1% of the fund
• Invesco Nasdaq Biotechnology ETF (IBBQ): 0.1% of the fund

Browse

• Stocks in United Kingdom
• Healthcare stocks in United Kingdom

Peers in Medical Care Facilities

• HCA Healthcare Inc (HCA)
• Tenet Healthcare Corp (THC)
• Encompass Health Corp (EHC)
• DaVita Inc (DVA)
• Fresenius Medical Care AG ADR (FMS)
• Ensign Group Inc (ENSG)
• Universal Health Services Inc (UHS)
• PACS Group Inc (PACS)

All 48 Medical Care Facilities stocks

Cheaper than CMPS in Medical Care Facilities

• Nutex Health Inc (NUTX): undervalued, 77% margin of safety
• Fresenius Medical Care AG ADR (FMS): undervalued, 70% margin of safety
• Ardent Health Inc (ARDT): undervalued, 69% margin of safety
• Universal Health Services Inc (UHS): undervalued, 64% margin of safety
• DaVita Inc (DVA): undervalued, 55% margin of safety
• Tenet Healthcare Corp (THC): undervalued, 51% margin of safety

25 more in this industry show a wider margin of safety.

Is CMPS undervalued or overvalued?

We do not publish a verdict on CMPS yet. We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.

What is the intrinsic value of CMPS?

We do not publish one (as of the 2026-10-30 close). We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.